BCMA BsAb Educational Initiatives in 2L+ Relapsed/Refractory Multiple MyelomaGrant · Pfizer · OncologyCloses Dec 18
Improving Quality of Care and Scalable Implementation of Bispecific Antibody Therapy in Multiple MyelomaGrant · Pfizer · OncologyCloses Jan 14, 2027